Actively Recruiting
Guided Optimisation of Long-term Disease rEduction in secoNdary Prevention of CVD
Led by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Updated on 2024-10-15
5586
Participants Needed
1
Research Sites
233 weeks
Total Duration
On this page
Sponsors
A
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Lead Sponsor
D
Dutch Network for Cardiovascular Research (WCN), Utrecht
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this observational study is to evaluate the implementation of a 'first-time-right' pharmacological treatment strategy in patients hospitalized with coronary artery disease. The main question it aims to answer is: Does early (immediately post-event) initiation of a full set of guideline-based, individualized, preventive medication lead to reductions in cardiovascular events compared to current practice (incremental titration strategies)? Researchers will compare the 'first-time-right' strategy group to the current practice group to see if there are improvements in major adverse cardiac and cerebrovascular events (MACE) at 36 months. Participants will: * Receive either the 'first-time-right' strategy or current practice for secondary prevention. * Be monitored (data collection) through routine clinical visits at baseline, 8 weeks, 12, and additional telephone contacts at 24, and 36 months after discharge. * Complete online questionnaires at hospitalization, 8 weeks, 12, 24, and 36 months after discharge.
CONDITIONS
Official Title
Guided Optimisation of Long-term Disease rEduction in secoNdary Prevention of CVD
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Over 18 years of age
- Recent coronary event such as acute coronary syndrome or coronary revascularization
- Able to provide informed consent
You will not qualify if you...
- Currently pregnant or breastfeeding or planning pregnancy soon
- Receiving dialysis treatment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Amsterdam UMC
Amsterdam, Netherlands
Actively Recruiting
Research Team
M
Manon van den Bogaart, drs.
CONTACT
M
Marjolein Snaterse, dr.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here